📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. (2017)

First Author: Read ML

Attributed to: RE-ENGINEERING RADIOIODINE THERAPY FOR THE 21ST CENTURY funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2017.154

PubMed Identifier: 28504713

Publication URI: http://europepmc.org/abstract/MED/28504713

Type: Journal Article/Review

Volume: 36

Parent Publication: Oncogene

Issue: 37

ISSN: 0950-9232